ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000001039
Date of registration:	18/02/2008
Prospective Registration:	No
Primary sponsor:	National Hospital for Geriatrics Medicine
Public title:	A randomized placebo-controlled study of small dose and short duration Haloperidol prophylaxis for elderly at risk for postoperative delirium.
Scientific title:	A randomized placebo-controlled study of small dose and short duration Haloperidol prophylaxis for elderly at risk for postoperative delirium. - RCT study of Haloperidol for postoperative delirium
Date of first enrolment:	2007/12/01
Target sample size:	120
Recruitment status:
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001247
Study type:	Interventional
Study design:	Parallel Randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Junichi Kamiya
Address:	Ibohara 500-1, Jousui, Toyota city, Aichi Japan
Telephone:	0565-31-1511
Email:
Affiliation:	Aichiken-Kouseiren-Toyota-Kousei Hospital department of surgery

Name:	Hideyuki Hattori
Address:	Gengo 36-3, Morioka, Obu city, Aichi Japan
Telephone:	0562-46-2311
Email:
Affiliation:	National Hospital for Geriatrics Medicine Department of Psychiatry

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: Emergency surgery. Case of having done treatment intervention on the 0th day (that day of operation) of after the operation.

Age minimum: 75years-old
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

postoperative delirium

Intervention(s)

Haloperidol 2.5mg will administrated with drip infusion for 3 days after operation in the intervention group. No treatment will be applied to the control group.
No treatment will be applied to the control group.

Primary Outcome(s)

Behavioral and psychological disorders assessed with NEECHAM score will purchased from preoperative day to 7 days after operation consecutively.

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Ministry of Health, Labour and Welfare

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:	Yes
Date Posted:
Date Completed:	01/12/2010
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.